These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28657673)

  • 41. [New psychoactive substances require a paradigm shift in drug testing in Denmark].
    Breindahl T; Hindersson P; Leutscher PD; Kimergård A
    Ugeskr Laeger; 2018 Mar; 180(11):. PubMed ID: 29530235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Procedural aspects and interpretation problems in the analysis of drugs of abuse].
    Mancinelli R; Guiducci MS
    Ann Ist Super Sanita; 2002; 38(3):305-13. PubMed ID: 12645182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid drug detection in oral samples by porous silicon assisted laser desorption/ionization mass spectrometry.
    Lowe RD; Guild GE; Harpas P; Kirkbride P; Hoffmann P; Voelcker NH; Kobus H
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3543-8. PubMed ID: 19844964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
    Samyn N; De Boeck G; Verstraete AG
    J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations for the reliable detection of illicit drugs in urine in the European Union, with special attention to the workplace. EU Toxicology Experts working Group.
    de la Torre R; Segura J; de Zeeuw R; Williams J
    Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():339-44. PubMed ID: 9247664
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laboratory tests for rapid screening of drugs of abuse in the workplace: a review.
    Schwartz RH; Clark HW; Meek PS
    J Addict Dis; 1993; 12(2):43-56. PubMed ID: 8476942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm.
    Dyer KR; Wilkinson C
    Drug Alcohol Rev; 2008 Jan; 27(1):99-107. PubMed ID: 18034388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New technology and new initiatives in U.S. workplace testing.
    Walsh JM
    Forensic Sci Int; 2008 Jan; 174(2-3):120-4. PubMed ID: 17434275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral fluid testing: promises and pitfalls.
    Huestis MA; Verstraete A; Kwong TC; Morland J; Vincent MJ; de la Torre R
    Clin Chem; 2011 Jun; 57(6):805-10. PubMed ID: 21350039
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.
    Verstraete AG
    Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of drug concentrations between whole blood and oral fluid.
    Langel K; Gjerde H; Favretto D; Lillsunde P; Øiestad EL; Ferrara SD; Verstraete AG
    Drug Test Anal; 2014 May; 6(5):461-71. PubMed ID: 24039237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Wood M; Laloup M; Ramirez Fernandez Mdel M; Jenkins KM; Young MS; Ramaekers JG; De Boeck G; Samyn N
    Forensic Sci Int; 2005 Jun; 150(2-3):227-38. PubMed ID: 15944064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drugs and driving: the Finnish perspective.
    Lillsunde P; Gunnar T
    Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The sweat matrix: a new perspective for drugs analysis.
    Fucci N; De Giovanni N; Pascali VL
    Skin Res Technol; 2015 Feb; 21(1):129-30. PubMed ID: 25060804
    [No Abstract]   [Full Text] [Related]  

  • 58. SUBPART F--drug testing laboratories.
    Occup Health Saf; 2000 Apr; 69(4):40-6, 109. PubMed ID: 11396026
    [No Abstract]   [Full Text] [Related]  

  • 59. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
    Logan BK; Mohr AL; Talpins SK
    J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Proposal of psychomotor skill assessment tests for drivers and a protocol for sampling and testing of saliva, blood and urine when there is reason to suspect involvement of substances with alcohol-like effect].
    Wiergowski M; Jankowski Z; Tomczak E; Anand JS; Ziółkowski R; Staniszewski J
    Arch Med Sadowej Kryminol; 2012; 62(3):186-96. PubMed ID: 23650844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.